Review Article
Omega-3 Fatty Acids in Early Prevention of Inflammatory Neurodegenerative Disease: A Focus on Alzheimer’s Disease
Table 3
Summary of DHA/EPA dietary intervention trials in patients with mild cognitive impairment (MCI) in the last 10 years.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
AA = arachidonic acid; DHA = docosahexaenoic acid; EPA = eicosapentaenoic acid; MMSE = Minimental State Examination; ADAS-cog. = Cognitive Portion of the Alzheimer’s Disease Assessment Scale; CIBIC plus = Clinician’s Interview-Based Impression of Change Scale; RBANS = Repeatable Battery for the Assessment of Neuropsychological Status; RAVLT = Rey’s Auditory Verbal Learning Test; CDT = Clock Drawing Test; WAIS-R = Wechsler Adult Intelligence Scale; AMT = Abbreviated Mental Test. |